Stock listing

Mink Therapeutics, Inc.

Selected listing: 6Q40 · MUN · EUR · DE

Mink Therapeutics, Inc. (Munich:6Q40), Health Technology. Latest release Oct 2, 2026: MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal…

6Q40:MUNEURDEUpdated October 2, 2026

Ticker: Munich:6Q40
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Munich
Currency: EUR

Latest news from Mink Therapeutics, Inc.

MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026

October 2, 2026

MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026

October 1, 2026

MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy

September 30, 2026

MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury

August 13, 2026

MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates

August 6, 2026

All Mink Therapeutics, Inc. news →

Events

Replays

MiNK Therapeutics, Inc. (INKT) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 08:30 AM ET
Watch
MiNK Therapeutics, Inc. (INKT) Q1 2026 Earnings Call
Fri, May 15, 2026 · 08:30 AM ET
Watch
MiNK Therapeutics, Inc. (INKT) Q4 2025 Earnings Call
Tue, Mar 31, 2026 · 08:30 AM ET
Watch

Research Mink Therapeutics, Inc.

Mink Therapeutics, Inc. company profile

View the public company page for Mink Therapeutics, Inc. on 6ix.

Mink Therapeutics, Inc. news

Read company news and market updates connected to Mink Therapeutics, Inc..

Mink Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Mink Therapeutics, Inc..